Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.
Dunn A, Dargaud Y, Abajas Y, Carcao M, Castaman G, Giermasz A, Hermans C, Jiménez-Yuste V, Lewandowska M, Mahlangu J, Meeks S, Miesbach W, Recht M, Salinas V, Chrisentery-Singleton T, Bonzo D, Mitchell IS, Wilkinson TA, Young G.
Dunn A, et al. Among authors: lewandowska m.
Haemophilia. 2024 Dec 15. doi: 10.1111/hae.15109. Online ahead of print.
Haemophilia. 2024.
PMID: 39676340